Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06359028 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT06359028 is a NA study that has completed, run by HALEON. The registered enrollment target is 111 participants.
The verdict
NCT06359028, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.
Interventions
- DRUG Stannous fluoride toothpaste
- DRUG Crest cavity protection toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2024-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06359028
The ClinicalTrials.gov registry entry for NCT06359028 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stannous fluoride toothpaste is the first listed.
NCT06359028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06359028 about?
NCT06359028 is a clinical study titled "Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers". The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.
What is the current status of trial NCT06359028?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2024-03-25. Estimated completion is 2024-06-20.
What interventions are being tested in trial NCT06359028?
The interventions under investigation include: Stannous fluoride toothpaste (DRUG), Crest cavity protection toothpaste (DRUG).
Who is sponsoring clinical trial NCT06359028?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.